238 related articles for article (PubMed ID: 25896649)
1. Central nervous system acute lymphoblastic leukemia: role of natural killer cells.
Frishman-Levy L; Shemesh A; Bar-Sinai A; Ma C; Ni Z; Frenkel S; Muench V; Bruckmueller H; Vokuhl C; Debatin KM; Eckert C; Stanulla M; Schrappe M; Campbell KS; Loewenthal R; Schewe DM; Hochman J; Meyer LH; Kaufman D; Cario G; Porgador A; Izraeli S
Blood; 2015 May; 125(22):3420-31. PubMed ID: 25896649
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity.
Satwani P; Bavishi S; Saha A; Zhao F; Ayello J; van de Ven C; Chu Y; Cairo MS
Cytotherapy; 2014 Oct; 16(10):1431-40. PubMed ID: 24856896
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor.
Münch V; Trentin L; Herzig J; Demir S; Seyfried F; Kraus JM; Kestler HA; Köhler R; Barth TFE; Te Kronnie G; Debatin KM; Meyer LH
Blood; 2017 Aug; 130(5):643-654. PubMed ID: 28550041
[TBL] [Abstract][Full Text] [Related]
4. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.
Siegler U; Kalberer CP; Nowbakht P; Sendelov S; Meyer-Monard S; Wodnar-Filipowicz A
Leukemia; 2005 Dec; 19(12):2215-22. PubMed ID: 16224486
[TBL] [Abstract][Full Text] [Related]
5. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia.
Kumar A; Taghi Khani A; Duault C; Aramburo S; Sanchez Ortiz A; Lee SJ; Chan A; McDonald T; Huang M; Lacayo NJ; Sakamoto KM; Yu J; Hurtz C; Carroll M; Tasian SK; Ghoda L; Marcucci G; Gu Z; Rosen ST; Armenian S; Izraeli S; Chen CW; Caligiuri MA; Forman SJ; Maecker HT; Swaminathan S
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217248
[TBL] [Abstract][Full Text] [Related]
7. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
[TBL] [Abstract][Full Text] [Related]
8. The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.
Williams MT; Yousafzai YM; Elder A; Rehe K; Bomken S; Frishman-Levy L; Tavor S; Sinclair P; Dormon K; Masic D; Perry T; Weston VJ; Kearns P; Blair H; Russell LJ; Heidenreich O; Irving JA; Izraeli S; Vormoor J; Graham GJ; Halsey C
Blood; 2016 Apr; 127(16):1998-2006. PubMed ID: 26869395
[TBL] [Abstract][Full Text] [Related]
9. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
10. RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia.
Holland M; Castro FV; Alexander S; Smith D; Liu J; Walker M; Bitton D; Mulryan K; Ashton G; Blaylock M; Bagley S; Connolly Y; Bridgeman J; Miller C; Krishnan S; Dempsey C; Masurekar A; Stern P; Whetton A; Saha V
Blood; 2011 Jul; 118(3):638-49. PubMed ID: 21606482
[TBL] [Abstract][Full Text] [Related]
11. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.
Cario G; Izraeli S; Teichert A; Rhein P; Skokowa J; Möricke A; Zimmermann M; Schrauder A; Karawajew L; Ludwig WD; Welte K; Schünemann HJ; Schlegelberger B; Schrappe M; Stanulla M
J Clin Oncol; 2007 Oct; 25(30):4813-20. PubMed ID: 17947730
[TBL] [Abstract][Full Text] [Related]
12. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
[TBL] [Abstract][Full Text] [Related]
13. Decitabine enhances targeting of AML cells by CD34
Cany J; Roeven MWH; Hoogstad-van Evert JS; Hobo W; Maas F; Franco Fernandez R; Blijlevens NMA; van der Velden WJ; Huls G; Jansen JH; Schaap NPM; Dolstra H
Blood; 2018 Jan; 131(2):202-214. PubMed ID: 29138222
[TBL] [Abstract][Full Text] [Related]
14. Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells.
Torelli GF; Peragine N; Raponi S; Pagliara D; De Propris MS; Vitale A; Bertaina A; Barberi W; Moretta L; Basso G; Santoni A; Guarini A; Locatelli F; Foà R
Haematologica; 2014 Jul; 99(7):1248-54. PubMed ID: 24658822
[TBL] [Abstract][Full Text] [Related]
15. CRTAM
Ramírez-Ramírez D; Padilla-Castañeda S; Galán-Enríquez CS; Vadillo E; Prieto-Chávez JL; Jiménez-Hernández E; Vilchis-Ordóñez A; Sandoval A; Balandrán JC; Pérez-Tapia SM; Ortiz-Navarrete V; Pelayo R
J Leukoc Biol; 2019 May; 105(5):999-1013. PubMed ID: 30791148
[TBL] [Abstract][Full Text] [Related]
16. The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous system.
Alsadeq A; Fedders H; Vokuhl C; Belau NM; Zimmermann M; Wirbelauer T; Spielberg S; Vossen-Gajcy M; Cario G; Schrappe M; Schewe DM
Haematologica; 2017 Feb; 102(2):346-355. PubMed ID: 27686375
[TBL] [Abstract][Full Text] [Related]
17. hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions.
Jiang W; Zhang C; Tian Z; Zhang J
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1279-1288. PubMed ID: 29737430
[TBL] [Abstract][Full Text] [Related]
18. High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia.
Müller S; Bexte T; Gebel V; Kalensee F; Stolzenberg E; Hartmann J; Koehl U; Schambach A; Wels WS; Modlich U; Ullrich E
Front Immunol; 2019; 10():3123. PubMed ID: 32117200
[TBL] [Abstract][Full Text] [Related]
19. The anti-tumor role of NK cells in vivo pre-activated and re-stimulated by interleukins in acute lymphoblastic leukemia.
Jin F; Lin H; Gao S; Hu Z; Zuo S; Sun L; Jin C; Li W; Yang Y
Oncotarget; 2016 Nov; 7(48):79187-79202. PubMed ID: 27816971
[TBL] [Abstract][Full Text] [Related]
20. An Hsp70 peptide initiates NK cell killing of leukemic blasts after stem cell transplantation.
Gross C; Holler E; Stangl S; Dickinson A; Pockley AG; Asea AA; Mallappa N; Multhoff G
Leuk Res; 2008 Apr; 32(4):527-34. PubMed ID: 17543383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
